Oct 18, 2019
30 Sept. 2019, UKCoronary heart disease is one of the leading causes of death within the UK. Every day over 2500 patients present at A&E departments across the UK with chest pain, indicative of a suspected heart attack. Of these, only 20% will have a confirmed heart attack. Diagnosis often takes several hours after arriving at A&E while healthcare professionals wait for test results to be processed by the hospital laboratory. Faster identification of these patients will save lives and im...
Sep 27, 2019
Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core markets and support other global diagnostics R&D facilities
Sep 10, 2019
Studies confirm strong analytical performance for body fluid and pathological sample analysis of HELO platform
Jul 26, 2019
Specific, intermediate glycemic control marker for diabetes at EKF’s Booth #2952 at AACC 2019 Clinical Lab Expo – 6-8th August 2019
Jul 16, 2019
POC HbA1c study at Great Western Hospitals NHS Foundation Trust is finalist for
2019 RCOphth/Bausch+Lomb Sustainability Prize
Jun 17, 2019
Oxford, UK – 13 June 2019. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq™ portfolio with a complete library preparation solution for hybridisation-based target capture in NGS, making its market-leading coverage uniformity and expertise even more accessible.
May 28, 2019
Northampton, UK – 28th May 2019 – HORIBA UK Ltd, Medical announces the go live of the first multi-site installation of its new HELO high throughput fully automated haematology platform within the Cardiff and Vale University Health Board. The new system is already delivering laboratory efficiencies across Cardiff in line with NHS requirements through the next generation haematology analysers installed at the University Hospital of Wales (UHW) and University Hospital, Llandough. Both sites are f...
May 20, 2019
Seralite®– FLC Serum granted registration by the Brazilian Health Regulatory Agency (ANVISA)
Abingdon Health is pleased to announce Seralite® – FLC Serum has been granted registration by the Brazilian Health Regulatory Agency (ANVISA)
Mar 29, 2019
The Leiden based biotechnology firm Idris Oncology is one of the three SME’s in Europe to receive human tissue through the Codex4SME’s consortium, in order to help them progress their diagnostic product towards clinical application.
Mar 27, 2019
New Yumizen GDDi 2 (D-Dimer) reagent kit for DVT and Pulmonary Embolism diagnosis